StockStory.org on MSN
Illumina (NASDAQ:ILMN) Beats Q3 Sales Expectations
Genomics company Illumina (NASDAQ:ILMN) in Q3 CY2025, but sales were flat year on year at $1.08 billion. Its non-GAAP profit of $1.34 per share was 14.7% above analysts’ consensus estimates. Is now ...
Chemists at the National University of Singapore (NUS) have found a new use for deoxyribonucleic acid (DNA), not just as ...
Scientists at the Leibniz Institute of Photonic Technology (Leibniz IPHT) have developed a new microarray-based diagnostic ...
Faulty versions of the LMNA gene can cause a wide range of health problems, including heart muscle disease (dilated cardiomyopathy) and muscle weakness (muscular dystrophies). Many of these diseases ...
Our experiences leave traces in the brain, stored in small groups of cells called engrams. Engrams are thought to hold the ...
According to Nova One Advisor, the global genomics data analysis market size is calculated at USD 7.91 billion in 2025 and is ...
Thank you, Sabrina, and good morning, everyone. The third quarter was another exceptional quarter for GeneDx. Achieving that vision requires a fast-growing, disciplined, profitable business that ...
This study offers a valuable methodological advance by introducing a gene panel selection approach that captures combinatorial specificity to define cell identity. The findings address key limitations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results